2024/01/09
Dear colleagues and friends,
It was a great honor for us to host many of you from around the world in San Francisco for the 12th WuXi Global Forum on January 9, 2024, coinciding with the 2024 J.P. Morgan Healthcare Conference.
The theme of this year’s forum is B.O.L.D. We reflected on the state of innovation and highlighted our industry’s notable advances in tackling innovation challenges to build an impactful future for patients: Breaking Barriers, Opening New Horizons, Leading Next Generation and Delivering on the Promise for Patients.
Special thanks to our supportive partners: A*STAR, BioCentury, Biocom California, BioWorld, California Life Sciences, Davos Alzheimer's Collaborative, Endpoints News, GEN, Medicon Valley Alliance, Swiss Biotech Association and UK BioIndustry Association.
Agenda
11:30 AM - 01:30 PM Badge Pickup and Onsite Check-in
01:30 PM - 01:35 PM Welcome
Hui Cai, Program Chair and Vice President, WuXi AppTec
01:35 PM - 01:45 PM Opening Remarks
Minzhang Chen, Co-CEO, WuXi AppTec
01:45 PM - 02:30 PM State of Innovation 2024
Amy Abernethy, CMO & President, Product Development, Verily
Donald Ingber, Founding Director & Chaired Professor, Wyss Institute at Harvard University
Mathai Mammen, CEO & Chairman, FogPharma
John Maraganore, CEO, JMM Innovations
Søren Møller, Managing Partner, Seed Investments, Novo Holdings
Session Leader: Christoph Westphal, Co-Founder & General Partner, Longwood Fund
Spotlight on B.O.L.D.
02:30 PM - 03:00 PM Breaking Barriers. Leaping Forward.
Robert Gabbay, CSO & CMO, American Diabetes Association
Karen Knudsen, CEO, American Cancer Society and ACS CAN; Professor, Sidney Kimmel Cancer Center at Jefferson Health
Joseph Wu, President, American Heart Association; Director, Stanford Cardiovascular Institute; Co-Founder, Greenstone Biosciences
Session Leader: Margo Georgiadis, Co-Founder & CEO, Montai Health; CEO-Partner, Flagship Pioneering
03:00 PM - 03:45 PM Opening Up New Horizons: Spotlight on Cancer
Philip Kantoff, Co-Founder & CEO, Convergent Therapeutics
Samir Khleif, Founder & CEO, Georgiamune
Crystal Mackall, Professor of Pediatrics and Medicine, Stanford University; Director, Stanford Center for Cancer Cell Therapy
Briggs Morrison, CEO, Crossbow Therapeutics
Session Leader: Karen Tkach Tuzman, Director, Biopharma Intelligence, BioCentury
03:45 PM - 04:30 PM Leading Transformation: The Next Wave Therapeutics
Wolfram Carius, EVP Pharmaceuticals, Bayer
Abraham Ceesay, CEO, Rapport Therapeutics
Pavan Cheruvu, President & CEO, Bitterroot Bio
Giuseppe “Pino” Ciaramella, Co-Founder & CEO, Orbital Therapeutics; President, Beam Therapeutics
Kevin Forrest, Co-Founder, President & CEO, Kate Therapeutics
Amber Salzman, CEO, Epic Bio
Session Leader: Edward Hu, Vice Chairman, WuXi AppTec; CEO, WuXi Advanced Therapies
04:30 PM - 05:15 PM Delivering on Future Platform Solutions
Miles Congreve, CSO, Isomorphic Labs
Evan Feinberg, Co-Founder & CEO, Genesis Therapeutics
Nevan Krogan, Co-Founder & President, Rezo Therapeutics; Professor, Cellular and Molecular Pharmacology, UCSF; Investigator, J. David Gladstone Institutes
Ann Lee-Karlon, President & CEO, EpiBiologics
Sabrina Yang, Co-Founder & CIO, Empress Therapeutics; Principal, Flagship Pioneering
Session Leader: John Carroll, Editor & Founder, Endpoints News
05:15 PM - 06:00 PM Scaling Breakthroughs Forward
Vineeta Agarwala, General Partner, Andreessen Horowitz (a16z) Bio + Health
Alexis Borisy, Co-Founder & Chairman, Curie.Bio
Laura Furmanski, Partner, Patient Square Capital
Rogier Rooswinkel, General Partner, Forbion
Tim Shannon, General Partner, Canaan
John Wesley, Investment Director, NVentures
Session Leader: Steve Yang, Co-CEO, WuXi AppTec
06:00 PM - 07:00 PM Forum Closing and Reception
Please click here for the speaker bio